Apolipoprotein E genotype and mortality: Findings from the Cache County Study

Kathleen M. Hayden, Peter P Zandi, Constantine G Lyketsos, JoAnn T. Tschanz, Maria C. Norton, Ara S. Khachaturian, Carl F. Pieper, Kathleen A. Welsh-Bohmer, John C.S. Breitner

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To evaluate the association between apolipoprotein E (apo E) ε4 and mortality, the population attributable risk for mortality with ε4, and relative contributions of cardiovascular disease (CVD) and Alzheimer's disease (AD). DESIGN: Population-based cohort study. SETTING: Community-based. PARTICIPANTS: Permanent residents of Cache County, Utah, aged 65 and older as of January 1, 1995. MEASUREMENTS: Participants were genotyped at the apo E locus using buccal-swab deoxyribonucleic acid. Cardiovascular health was ascertained using self- or proxy-report interviews at participants' residences. AD was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria. Utah Department of Vital Statistics quarterly reports were reviewed to identify participants who died. RESULTS: Crude evaluations showed nonsignificantly greater risk of death for ε2/2 (hazard ratio (HR) = 1.66, 95% confidence interval (CI) = 0.92-2.76) and ε3/4 (HR = 1.11, 95% CI = 0.97-1.26) genotypes and significantly greater risk for ε4/4 (HR= 1.48, 95% CI = 1.09-1.96). After adjustment for age, age2, sex, and education, risks increased to 1.98 (95% CI = 1.08-3.35), 1.28 (95% CI = 1.12-1.46), and 2.02 (95% CI= 1.47-2.71), respectively, compared with ε3/3 genotypes. Adjustment for presence of any CVD did not change the risk of death for ε3/4 and ε4/4. Adjustment for AD reduced the risk of death for ε3/4 (HR = 1.13, 95% CI = 0.99-1.30) and ε4/4 (HR = 1.59, 95% CI = 1.15-2.14). The population attributable risk of death for ε3/4 and ε4/4 genotypes combined is estimated at 9.6%. CONCLUSION: These findings suggested that the ε2/2, ε3/4, and ε4/4 genotypes have greater early mortality risks. Further analyses showed that AD partially mediates the association between ε3/4, ε4/4, and death.

Original languageEnglish (US)
Pages (from-to)935-942
Number of pages8
JournalJournal of the American Geriatrics Society
Volume53
Issue number6
DOIs
StatePublished - Jun 2005

Fingerprint

Apolipoproteins E
Genotype
Confidence Intervals
Mortality
Alzheimer Disease
Cardiovascular Diseases
National Institute of Neurological Disorders and Stroke
Population
Communication Disorders
Apolipoprotein E4
Vital Statistics
Sex Education
Cheek
Proxy
Diagnostic and Statistical Manual of Mental Disorders
Cohort Studies
Interviews
DNA
Health

Keywords

  • Alzheimer's disease
  • Apolipoprotein E
  • Cardiovascular disease
  • Mortality

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Apolipoprotein E genotype and mortality : Findings from the Cache County Study. / Hayden, Kathleen M.; Zandi, Peter P; Lyketsos, Constantine G; Tschanz, JoAnn T.; Norton, Maria C.; Khachaturian, Ara S.; Pieper, Carl F.; Welsh-Bohmer, Kathleen A.; Breitner, John C.S.

In: Journal of the American Geriatrics Society, Vol. 53, No. 6, 06.2005, p. 935-942.

Research output: Contribution to journalArticle

Hayden, Kathleen M. ; Zandi, Peter P ; Lyketsos, Constantine G ; Tschanz, JoAnn T. ; Norton, Maria C. ; Khachaturian, Ara S. ; Pieper, Carl F. ; Welsh-Bohmer, Kathleen A. ; Breitner, John C.S. / Apolipoprotein E genotype and mortality : Findings from the Cache County Study. In: Journal of the American Geriatrics Society. 2005 ; Vol. 53, No. 6. pp. 935-942.
@article{f97336c93d75405483b2cf4ddac84eac,
title = "Apolipoprotein E genotype and mortality: Findings from the Cache County Study",
abstract = "OBJECTIVES: To evaluate the association between apolipoprotein E (apo E) ε4 and mortality, the population attributable risk for mortality with ε4, and relative contributions of cardiovascular disease (CVD) and Alzheimer's disease (AD). DESIGN: Population-based cohort study. SETTING: Community-based. PARTICIPANTS: Permanent residents of Cache County, Utah, aged 65 and older as of January 1, 1995. MEASUREMENTS: Participants were genotyped at the apo E locus using buccal-swab deoxyribonucleic acid. Cardiovascular health was ascertained using self- or proxy-report interviews at participants' residences. AD was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria. Utah Department of Vital Statistics quarterly reports were reviewed to identify participants who died. RESULTS: Crude evaluations showed nonsignificantly greater risk of death for ε2/2 (hazard ratio (HR) = 1.66, 95{\%} confidence interval (CI) = 0.92-2.76) and ε3/4 (HR = 1.11, 95{\%} CI = 0.97-1.26) genotypes and significantly greater risk for ε4/4 (HR= 1.48, 95{\%} CI = 1.09-1.96). After adjustment for age, age2, sex, and education, risks increased to 1.98 (95{\%} CI = 1.08-3.35), 1.28 (95{\%} CI = 1.12-1.46), and 2.02 (95{\%} CI= 1.47-2.71), respectively, compared with ε3/3 genotypes. Adjustment for presence of any CVD did not change the risk of death for ε3/4 and ε4/4. Adjustment for AD reduced the risk of death for ε3/4 (HR = 1.13, 95{\%} CI = 0.99-1.30) and ε4/4 (HR = 1.59, 95{\%} CI = 1.15-2.14). The population attributable risk of death for ε3/4 and ε4/4 genotypes combined is estimated at 9.6{\%}. CONCLUSION: These findings suggested that the ε2/2, ε3/4, and ε4/4 genotypes have greater early mortality risks. Further analyses showed that AD partially mediates the association between ε3/4, ε4/4, and death.",
keywords = "Alzheimer's disease, Apolipoprotein E, Cardiovascular disease, Mortality",
author = "Hayden, {Kathleen M.} and Zandi, {Peter P} and Lyketsos, {Constantine G} and Tschanz, {JoAnn T.} and Norton, {Maria C.} and Khachaturian, {Ara S.} and Pieper, {Carl F.} and Welsh-Bohmer, {Kathleen A.} and Breitner, {John C.S.}",
year = "2005",
month = "6",
doi = "10.1111/j.1532-5415.2005.53301.x",
language = "English (US)",
volume = "53",
pages = "935--942",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Apolipoprotein E genotype and mortality

T2 - Findings from the Cache County Study

AU - Hayden, Kathleen M.

AU - Zandi, Peter P

AU - Lyketsos, Constantine G

AU - Tschanz, JoAnn T.

AU - Norton, Maria C.

AU - Khachaturian, Ara S.

AU - Pieper, Carl F.

AU - Welsh-Bohmer, Kathleen A.

AU - Breitner, John C.S.

PY - 2005/6

Y1 - 2005/6

N2 - OBJECTIVES: To evaluate the association between apolipoprotein E (apo E) ε4 and mortality, the population attributable risk for mortality with ε4, and relative contributions of cardiovascular disease (CVD) and Alzheimer's disease (AD). DESIGN: Population-based cohort study. SETTING: Community-based. PARTICIPANTS: Permanent residents of Cache County, Utah, aged 65 and older as of January 1, 1995. MEASUREMENTS: Participants were genotyped at the apo E locus using buccal-swab deoxyribonucleic acid. Cardiovascular health was ascertained using self- or proxy-report interviews at participants' residences. AD was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria. Utah Department of Vital Statistics quarterly reports were reviewed to identify participants who died. RESULTS: Crude evaluations showed nonsignificantly greater risk of death for ε2/2 (hazard ratio (HR) = 1.66, 95% confidence interval (CI) = 0.92-2.76) and ε3/4 (HR = 1.11, 95% CI = 0.97-1.26) genotypes and significantly greater risk for ε4/4 (HR= 1.48, 95% CI = 1.09-1.96). After adjustment for age, age2, sex, and education, risks increased to 1.98 (95% CI = 1.08-3.35), 1.28 (95% CI = 1.12-1.46), and 2.02 (95% CI= 1.47-2.71), respectively, compared with ε3/3 genotypes. Adjustment for presence of any CVD did not change the risk of death for ε3/4 and ε4/4. Adjustment for AD reduced the risk of death for ε3/4 (HR = 1.13, 95% CI = 0.99-1.30) and ε4/4 (HR = 1.59, 95% CI = 1.15-2.14). The population attributable risk of death for ε3/4 and ε4/4 genotypes combined is estimated at 9.6%. CONCLUSION: These findings suggested that the ε2/2, ε3/4, and ε4/4 genotypes have greater early mortality risks. Further analyses showed that AD partially mediates the association between ε3/4, ε4/4, and death.

AB - OBJECTIVES: To evaluate the association between apolipoprotein E (apo E) ε4 and mortality, the population attributable risk for mortality with ε4, and relative contributions of cardiovascular disease (CVD) and Alzheimer's disease (AD). DESIGN: Population-based cohort study. SETTING: Community-based. PARTICIPANTS: Permanent residents of Cache County, Utah, aged 65 and older as of January 1, 1995. MEASUREMENTS: Participants were genotyped at the apo E locus using buccal-swab deoxyribonucleic acid. Cardiovascular health was ascertained using self- or proxy-report interviews at participants' residences. AD was diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, and National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria. Utah Department of Vital Statistics quarterly reports were reviewed to identify participants who died. RESULTS: Crude evaluations showed nonsignificantly greater risk of death for ε2/2 (hazard ratio (HR) = 1.66, 95% confidence interval (CI) = 0.92-2.76) and ε3/4 (HR = 1.11, 95% CI = 0.97-1.26) genotypes and significantly greater risk for ε4/4 (HR= 1.48, 95% CI = 1.09-1.96). After adjustment for age, age2, sex, and education, risks increased to 1.98 (95% CI = 1.08-3.35), 1.28 (95% CI = 1.12-1.46), and 2.02 (95% CI= 1.47-2.71), respectively, compared with ε3/3 genotypes. Adjustment for presence of any CVD did not change the risk of death for ε3/4 and ε4/4. Adjustment for AD reduced the risk of death for ε3/4 (HR = 1.13, 95% CI = 0.99-1.30) and ε4/4 (HR = 1.59, 95% CI = 1.15-2.14). The population attributable risk of death for ε3/4 and ε4/4 genotypes combined is estimated at 9.6%. CONCLUSION: These findings suggested that the ε2/2, ε3/4, and ε4/4 genotypes have greater early mortality risks. Further analyses showed that AD partially mediates the association between ε3/4, ε4/4, and death.

KW - Alzheimer's disease

KW - Apolipoprotein E

KW - Cardiovascular disease

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=23444451472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444451472&partnerID=8YFLogxK

U2 - 10.1111/j.1532-5415.2005.53301.x

DO - 10.1111/j.1532-5415.2005.53301.x

M3 - Article

C2 - 15935014

AN - SCOPUS:23444451472

VL - 53

SP - 935

EP - 942

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 6

ER -